169 related articles for article (PubMed ID: 34638257)
1. Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA).
Hau HM; Devantier M; Jahn N; Sucher E; Rademacher S; Seehofer D; Sucher R
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638257
[TBL] [Abstract][Full Text] [Related]
2. Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis.
Merath K; Mehta R; Hyer JM; Bagante F; Sahara K; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Ejaz A; Pawlik TM
Eur J Surg Oncol; 2019 Jun; 45(6):1084-1091. PubMed ID: 30871884
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study.
Liu ZP; Chen WY; Wang ZR; Liu XC; Fan HN; Xu L; Pan Y; Zhong SY; Xie D; Bai J; Jiang Y; Zhang YQ; Dai HS; Chen ZY
Front Oncol; 2022; 12():849053. PubMed ID: 35530316
[TBL] [Abstract][Full Text] [Related]
4. Radiographic features predictive of recurrence and survival after surgical resection of perihilar cholangiocarcinoma.
Promsorn J; Naknan P; Sookprasert A; Wirasorn K; Chindaprasirt J; Titapun A; Intarawichian P; Harisinghani M
Heliyon; 2024 Apr; 10(7):e28805. PubMed ID: 38617950
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis.
Tang Z; Yang Y; Zhao Z; Wei K; Meng W; Li X
Medicine (Baltimore); 2018 Aug; 97(34):e11999. PubMed ID: 30142840
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of prognostic factors for early recurrence in perihilar cholangiocarcinoma after curative-intent resection.
Tian Y; Wen N; Li B; Lu J; Wang Y; Wang S; Cheng N
Eur J Surg Oncol; 2023 Nov; 49(11):106982. PubMed ID: 37487828
[TBL] [Abstract][Full Text] [Related]
7. Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group.
Ruzzenente A; Bagante F; Olthof PB; Aldrighetti L; Alikhanov R; Cescon M; Koerkamp BG; Jarnagin WR; Nadalin S; Pratschke J; Schmelzle M; Sparrelid E; Lang H; Iacono C; van Gulik TM; Guglielmi A;
Ann Surg Oncol; 2021 Nov; 28(12):7719-7729. PubMed ID: 33956275
[TBL] [Abstract][Full Text] [Related]
8. Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma.
Pan Y; Liu ZP; Dai HS; Chen WY; Luo Y; Wang YZ; Gao SY; Wang ZR; Dong JL; Liu YH; Yin XY; Liu XC; Fan HN; Bai J; Jiang Y; Cheng JJ; Zhang YQ; Chen ZY
World J Gastrointest Oncol; 2023 Jun; 15(6):1036-1050. PubMed ID: 37389112
[TBL] [Abstract][Full Text] [Related]
9. Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection:
Liu ZP; Cheng ZJ; Dai HS; Zhong SY; Zhao DC; Gong Y; Zuo JH; Che XY; Chen WY; Wang ZR; Yu T; Cheng JJ; Liu XC; Bai J; Jiang Y; Zhang YQ; Lau WY; Deng SQ; Chen ZY
Front Oncol; 2022; 12():1059581. PubMed ID: 36387093
[TBL] [Abstract][Full Text] [Related]
10. Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup.
Zhao J; Zhang W; Zhang J; Chen YT; Ma WJ; Liu SY; Li FY; Song B
Cancer Manag Res; 2020; 12():13111-13123. PubMed ID: 33376403
[TBL] [Abstract][Full Text] [Related]
11. Nerve Fibers in the Tumor Microenvironment as a Novel Biomarker for Oncological Outcome in Patients Undergoing Surgery for Perihilar Cholangiocarcinoma.
Bednarsch J; Kather J; Tan X; Sivakumar S; Cacchi C; Wiltberger G; Czigany Z; Ulmer F; Neumann UP; Heij LR
Liver Cancer; 2021 Jun; 10(3):260-274. PubMed ID: 34239812
[TBL] [Abstract][Full Text] [Related]
12. Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry.
Nooijen LE; Banales JM; de Boer MT; Braconi C; Folseraas T; Forner A; Holowko W; Hoogwater FJH; Klümpen HJ; Groot Koerkamp B; Lamarca A; La Casta A; López-López F; Izquierdo-Sánchez L; Scheiter A; Utpatel K; Swijnenburg RJ; Kazemier G; Erdmann JI;
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625993
[TBL] [Abstract][Full Text] [Related]
13. [Surgical treatment for perihilar cholangiocarcinoma:a single-center experience].
Deng WY; Shi XD; Ye YF; Tang QB; Lin HM; Yu XH; Liu C
Zhonghua Wai Ke Za Zhi; 2023 Mar; 61(5):381-388. PubMed ID: 36987672
[No Abstract] [Full Text] [Related]
14. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
15. Body composition is associated with postoperative complications in perihilar cholangiocarcinoma.
Wang G; Mantas A; Heij LR; Al-Masri TM; Liu D; Heise D; Schmitz SM; Olde Damink SWM; Luedde T; Lang SA; Ulmer TF; Neumann UP; Bednarsch J
Cancer Med; 2024 Jan; 13(1):. PubMed ID: 38164056
[TBL] [Abstract][Full Text] [Related]
16. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
[TBL] [Abstract][Full Text] [Related]
17. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
18. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
[TBL] [Abstract][Full Text] [Related]
19. Multicentre study of the prognostic impact of preoperative bodyweight on long-term prognosis of hepatocellular carcinoma.
Yu JJ; Shen F; Chen TH; Liang L; Han J; Xing H; Zhou YH; Wang H; Gu WM; Lau WY; Yang T
Br J Surg; 2019 Feb; 106(3):276-285. PubMed ID: 30199100
[TBL] [Abstract][Full Text] [Related]
20. Metadherin overexpression in perihilar cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.
Zhu YZ; Zhou K; Ruan LL; Sun F; Wang G; Li WF
Oncol Lett; 2019 May; 17(5):4514-4520. PubMed ID: 30988817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
